BNP/CALL/MERCK & CO./115/0.1/20.12.24 Share Price

Warrant

DE000PN7E4D0

Market Closed - Deutsche Boerse AG 20:50:23 05/07/2024 BST
1.48 EUR +6.47% Intraday chart for BNP/CALL/MERCK & CO./115/0.1/20.12.24
Current month-3.27%
1 month-15.43%
Date Price Change
05/07/24 1.48 +6.47%
04/07/24 1.39 -2.80%
03/07/24 1.43 -11.18%
02/07/24 1.61 -2.42%
01/07/24 1.65 +7.84%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 08:50 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN7E4D
ISINDE000PN7E4D0
Date issued 17/08/2023
Strike 115 $
Maturity 20/12/2024 (166 Days)
Parity 10 : 1
Emission price 0.76
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.17
Lowest since issue 0.37
Spread 0.01
Spread %0.68%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus